BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 18771089)

  • 21. Oncogenic potential of Nrf2 and its principal target protein heme oxygenase-1.
    Na HK; Surh YJ
    Free Radic Biol Med; 2014 Feb; 67():353-65. PubMed ID: 24200599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential sensitivity in cell lines to photodynamic therapy in combination with ABCG2 inhibition.
    Barron GA; Moseley H; Woods JA
    J Photochem Photobiol B; 2013 Sep; 126():87-96. PubMed ID: 23911860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioengineered NRF2-siRNA Is Effective to Interfere with NRF2 Pathways and Improve Chemosensitivity of Human Cancer Cells.
    Li PC; Tu MJ; Ho PY; Jilek JL; Duan Z; Zhang QY; Yu AX; Yu AM
    Drug Metab Dispos; 2018 Jan; 46(1):2-10. PubMed ID: 29061583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced efficacy of photodynamic therapy by inhibiting ABCG2 in colon cancers.
    Kim JH; Park JM; Roh YJ; Kim IW; Hasan T; Choi MG
    BMC Cancer; 2015 Jul; 15():504. PubMed ID: 26149077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specific inhibition of the ABCG2 transporter could improve the efficacy of photodynamic therapy.
    Bebes A; Nagy T; Bata-Csörgo Z; Kemény L; Dobozy A; Széll M
    J Photochem Photobiol B; 2011 Nov; 105(2):162-6. PubMed ID: 21911299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of heme-oxygenase 1 requires the p38MAPK and PI3K pathways and suppresses apoptotic cell death following hypericin-mediated photodynamic therapy.
    Kocanova S; Buytaert E; Matroule JY; Piette J; Golab J; de Witte P; Agostinis P
    Apoptosis; 2007 Apr; 12(4):731-41. PubMed ID: 17219054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 5-Aminolevulinic acid combined with ferrous iron enhances the expression of heme oxygenase-1.
    Nishio Y; Fujino M; Zhao M; Ishii T; Ishizuka M; Ito H; Takahashi K; Abe F; Nakajima M; Tanaka T; Taketani S; Nagahara Y; Li XK
    Int Immunopharmacol; 2014 Apr; 19(2):300-7. PubMed ID: 24530569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The outcome of 5-ALA-mediated photodynamic treatment in melanoma cells is influenced by vitamin C and heme oxygenase-1.
    Grimm S; Mvondo D; Grune T; Breusing N
    Biofactors; 2011; 37(1):17-24. PubMed ID: 21328623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Photodynamic therapy using talaporfin sodium induces heme oxygenase-1 expression in rat malignant meningioma KMY-J cells.
    Takahashi T; Suzuki S; Misawa S; Akimoto J; Shinoda Y; Fujiwara Y
    J Toxicol Sci; 2018; 43(5):353-358. PubMed ID: 29743446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Irradiation inhibits the maturation and mineralization of osteoblasts via the activation of Nrf2/HO-1 pathway.
    Kook SH; Kim KA; Ji H; Lee D; Lee JC
    Mol Cell Biochem; 2015 Dec; 410(1-2):255-66. PubMed ID: 26346162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ATP-binding cassette transporter G2 mediates the efflux of phototoxins on the luminal membrane of retinal capillary endothelial cells.
    Asashima T; Hori S; Ohtsuki S; Tachikawa M; Watanabe M; Mukai C; Kitagaki S; Miyakoshi N; Terasaki T
    Pharm Res; 2006 Jun; 23(6):1235-42. PubMed ID: 16715370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Piceatannol induces heme oxygenase-1 expression in human mammary epithelial cells through activation of ARE-driven Nrf2 signaling.
    Lee HH; Park SA; Almazari I; Kim EH; Na HK; Surh YJ
    Arch Biochem Biophys; 2010 Sep; 501(1):142-50. PubMed ID: 20558128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 5-Aminolevulinic acid regulates the inflammatory response and alloimmune reaction.
    Fujino M; Nishio Y; Ito H; Tanaka T; Li XK
    Int Immunopharmacol; 2016 Aug; 37():71-78. PubMed ID: 26643355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ABCG2 expression is related to low 5-ALA photodynamic diagnosis (PDD) efficacy and cancer stem cell phenotype, and suppression of ABCG2 improves the efficacy of PDD.
    Kawai N; Hirohashi Y; Ebihara Y; Saito T; Murai A; Saito T; Shirosaki T; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Shichinohe T; Li L; Hirano S; Torigoe T
    PLoS One; 2019; 14(5):e0216503. PubMed ID: 31083682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Constitutive overexpression of Nrf2-dependent heme oxygenase-1 in A549 cells contributes to resistance to apoptosis induced by epigallocatechin 3-gallate.
    Kweon MH; Adhami VM; Lee JS; Mukhtar H
    J Biol Chem; 2006 Nov; 281(44):33761-72. PubMed ID: 16950787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nrf2 is increased by CYP2E1 in rodent liver and HepG2 cells and protects against oxidative stress caused by CYP2E1.
    Gong P; Cederbaum AI
    Hepatology; 2006 Jan; 43(1):144-53. PubMed ID: 16374848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural influence of isothiocyanates on the antioxidant response element (ARE)-mediated heme oxygenase-1 (HO-1) expression.
    Prawan A; Keum YS; Khor TO; Yu S; Nair S; Li W; Hu L; Kong AN
    Pharm Res; 2008 Apr; 25(4):836-44. PubMed ID: 17657593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Homocysteine induces heme oxygenase-1 expression via transcription factor Nrf2 activation in HepG2 cell.
    Mani M; Golmohammadi T; Khaghani S; Zamani Z; Azadmanesh K; Meshkani R; Pasalar P
    Iran Biomed J; 2013 Apr; 17(2):93-100. PubMed ID: 23567851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Small molecule activators of the Nrf2-HO-1 antioxidant axis modulate heme metabolism and inflammation in BV2 microglia cells.
    Foresti R; Bains SK; Pitchumony TS; de Castro Brás LE; Drago F; Dubois-Randé JL; Bucolo C; Motterlini R
    Pharmacol Res; 2013 Oct; 76():132-48. PubMed ID: 23942037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strongly amphiphilic photosensitizers are not substrates of the cancer stem cell marker ABCG2 and provides specific and efficient light-triggered drug delivery of an EGFR-targeted cytotoxic drug.
    Selbo PK; Weyergang A; Eng MS; Bostad M; Mælandsmo GM; Høgset A; Berg K
    J Control Release; 2012 Apr; 159(2):197-203. PubMed ID: 22349185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.